@genecentrix.com
GeneCentrix is a big polypharmacology, bioinformatics company and creator of the Historeceptomics Profiler, a tissue-specfic search engine that eases the clinical research and drug discovery process for biotech and pharmacology companies to help you sail through clinical trials and avoid attrition.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allIcon
JPEG
About
Description
GeneCentrix is a leading big data polypharmacology company specializing in software tools for early-stage drug discovery. Our flagship product is the HistoReceptomics Profiler, a cutting-edge tissue-specific bioinformatics tool. Using a proprietary algorithm, our platform identifies both the expected and unexpected tissues where a drug is likely to exhibit bioactivity.
This invaluable insight helps biotech and pharmacology companies streamline the clinical research and drug discovery process, reducing attrition rates and better preparing for clinical trials. Our mission at GeneCentrix is to provide advanced insights at all stages of the drug development process, ultimately reducing the odds of unexpected safety issues and improving the efficacy of drugs. By integrating big data and producing holistic anatomic information, we aim to enhance drug discovery workflows globally.
The HistoReceptomics Profiler is a user-friendly web platform that predicts the effects of a drug or compound on a wide range of human tissues, accounting for both off-target and on-target, off-tissue activity. This information is critical for drug development, design, and repurposing as it unveils tissue-specific effects during the preclinical stage. Founded in 2015, GeneCentrix originated as a commercialization venture for technologies developed at New York University School of Medicine.
Today, we are a privately held company based in New York City. With partnerships and collaborations with esteemed organizations such as NYU and Molsoft, we continually improve and expand our tools to make a significant impact on global drug development research. GeneCentrix is trusted by industry leaders such as Allergan Inc., now a subsidiary of AbbVie, who have contracted our services for HR R&D.
Supported by the National Institute of General Medical Sciences and the National Library of Medicine, we are at the forefront of revolutionizing drug discovery through innovative data-driven solutions. Stay up-to-date with the latest drug development news by subscribing to our newsletter, Attrition Zero. Join us on our mission to transform the future of drug discovery
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories